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Batch date on
straw (dd/mm/yy)
qPCR assay result
Positive (Ct < 40) Negative (Ct > 40) Total
18/09/2006 1 7 8
19/09/2006 6 4 10
29/09/2006 8 0 8
06/10/2008 1 0 1
16/08/2010 21 1 22
Semen straws (n) Sensitivity (%) Lower CI (%)
1 0.75 0.43
3 0.98 0.81
5 0.99 0.94
7 0.99 0.98
10 0.99 0.99
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for detecting T. equigenitalis DNA in frozen-thawed semen
collected from a Lipizzaner carrier-stallion identiﬁed during
epidemiological investigation of the ﬁrst South African CEM
outbreak in 2011 [2]. This stallion was recently linked to his cry-
opreserved semen collected between 2006-2010 prior to
outbreak recognition. Forty-nine 0.5 ml PVC straws from ﬁve
ejaculates (batches) processed using a cryopreservative extender
with added antimicrobials were recovered. All straws were
thawed and aliquots from each were transferred for both bacterial
isolation and qPCR assay using a modiﬁcation of an established
method [3]. The assay results summarised in Table 1 below
showed 37/49 (75.5%) straws were PCR-positive (Ct <40, range:
30.9-40). Bacterial isolation from all straws was negative.
Sensitivity of the qPCR assay for detecting T. equigenitalis DNA in
individual frozen-thawed straws (n¼49) from ﬁve ejaculates was
estimated as 1e (1-p)nwhere p¼ overall proportion of individual
qPCR positive straws and n ¼ number of straws tested (Table 2).
95% Conﬁdence Intervals were adjusted for the clustering of ob-
servations in the ﬁve ejaculates.
The qPCR assay effectively identiﬁed T. equigenitalis DNA
contaminating multiple straws of different ejaculates processed
over four years. Extensive variation in Ct values within and be-
tween batches was possibly due to effects of semen collection and
processing including addition of antibiotic-containing extender.
In conclusion, this data suggested that > three straws per batch
should be evaluated for 95% conﬁdence of detecting T. equi-
genitalis in cryopreserved semen from a potential carrier stallion
but the lower range of the 95% CI suggests a larger study is
necessary to improve precision of this estimate. Infectivity of the
bacterium after cryopreservation warrants further investigation.
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Re-emerging Equine Arteritis Virus (EAV) variants
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Equine viral arteritis (EVA), caused by the Equine Arteritis Virus
(EAV), is a disease of stallions notiﬁable in the UK and to the OIE,
but not in most other countries. However, with no active surveil-
lance in most countries (including the EU) and the clinical pre-
sentation mostly asymptomatic, EAV is often ﬁrst noticed when
causing issues for horses supposed to travel or to enter breeding
schemes. Although there is only one serotype of EAV, genetic
variation exists between ﬁeld strains of the virus. A segregation of
strains into European and North American lineages, wherein the
European lineage can be further divided into two clusters has been
attempted. Unsurprisingly, however, some European lineage vi-
ruses have been documented in North America and vice versa,
demonstrating the limits of this nomenclature as well as high-
lighting the transport of viruses via movement of horses and
semen. Over the last years we discovered a couple of EVA cases
through the analysis of horses that had been bought from conti-
nental Europe or were to be sold in the UK two of which shall be
presented here. In September 2012 we analysed a semen sample
from a stallion imported fromSpain, which tested positive for EAV.
Initial analysis of the ORF5 PCR product revealed the isolate to be
an outlier to previous phylogentic grouping, together with KY63
andH21. This demonstrates the re-emergence of a genotype across
decades and around the globe: KY63 is a ﬁeld strain isolated in
Kentucky in 1963; this isolate has always clustered separately from
other US isolates of the same time period suggesting a different
origin. Strain H21 appears to have been isolated in the early 2000's
in Hungary. Even considering a potential lack of sampling the case
demonstrates that established strains do not become extinct and
through global trade may re-appear unexpectedly, here in Spain
(UK) rather than Eastern Europe or the USA. The role of semen in
the transmission has been demonstrated in several outbreaks
recently, both in North and South America, as well as in Europe.
Previously, we analyzed another case of an imported stallion from
continental Europe. To our surprise this virus was very closely
related to the virus that has been linked to the Argentinian
outbreak in the same year, but as further analysis demonstrated
was not the only variant of EAV circulating at the time in Europe.
Therefore, highly similar and dissimilar variants of EAV are circu-
lating in parallel, using largely unexplored reservoirs for their
maintenance. Using all available data on full genome and ORF5
sequences a dynamic extended systematics is proposed for EAV.
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Treated horses Interval to
elimination of
T. equigenitalis (days)
A. Standard topical protocol
Lipizzaner (stallions: n¼23; gelding: n¼1) median: 11;
range: 9-52
Warmblood (stallion: n¼1) 10
Andalusian (stallion: n¼1) 9
Thoroughbred ( mare: n¼1) 14
B. Standard topical protocol plus
Curaclox® instillation
Warmblood (stallion: n¼1) 2
Warmblood (mare: n¼1) 2
10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S56eS65S62Infectious and Parasitic Diseases, FARAH Center, Faculty of
Veterinary Medicine, University of Liege, B-4000 Liege, Belgium;
5Catedra de Enfermedades Infecciosas, Escuela de Veterinaria,
Universidad del Salvador, Pilar, Buenos Aires, Argentina
Equine Coital Exanthema (ECE) is an infectious, venereally
transmitted mucocutaneous disease of mares and stallions
caused by Equid herpesvirus 3 (EHV3). Episodes of reactivation
and re-excretion in latently infected horses serve as a source of
virus, and thus the infection is endemic in horses worldwide.
Prevention for stallions is based on segregating affected mares
from reproduction. However, as the virus is reactivated from
latently infected animals and generally re-excreted subclini-
cally, and this is not predictable, the prevention approach
previously described does not eliminate the risk of contagion.
Lambda-carrageenans (l-carrageenans), which are sulfated
polysaccharides synthesized in great quantities by certain red
seaweed Gigartina skottsbergii (Gigartinaceae, Rhodophyta),
have demonstrated antiviral activity in vitro against Human
herpesvirus 1(HHV1) and 2 (HHV2) and some herpesviruses of
veterinary interest such as Bovine herpesvirus 1 (BoHV1), Suid
herpesvirus 1 (SuHV1) and Feline herpesvirus 1 (FeHV1). The
antiviral activity of l-carrageenan is likely due to its ability to
bind to the viral envelope glycoproteins and prevent virus
binding to cell surface receptors. The purpose of this study was
to evaluate the activity of l-carrageenans on EHV-3 in vitro.
Conﬂuent monolayers of EDerm cells were infected with 590
plaque forming units (PFU) of EHV-3 per well, simultaneously,
with different concentrations of l-carrageenans in a total vol-
ume of 500 ml. After 1 h of incubation at 37C, inoculum was
discarded and minimum essential medium supplemented with
carboxymethyl cellulose 0.75% was added. Cells infected with
the virus without l-carrageenans were used as a control. After
72 h of incubation, cells were ﬁxed and stained with 0.1%
formalin-buffered crystal violet solution. Inhibitory concentra-
tions 50 (IC50%) and 100 (IC100%), deﬁned as the concentra-
tions of the compound that reduce plaque number by 50% and
100% respectively, were determined. The IC50% of this com-
pound was 6.22 mg/ml but the IC100% could not be reached,
even at a concentration as high as 1g/ml. The IC50% (6.22 mg/
ml) found in this study for l-carrageenans against EHV3 is
higher than that found for HHV1 (1.6 mg/mL), HHV2 (1.5 mg/mL),
BoHV1 (0.52 mg/ml) and FeHV1 (5 mg/ml), but smaller than that
found for SuHV1 (10.42 mg/ml). According to our studies, l-
carragenans do not inhibit replication (100% inhibition) of EHV3
in vitro; thus, this compound used as a single component ap-
pears to be not eligible for the use in the prevention and
treatment of ECE.
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Based on the successful treatment of 27 T. equigentitalis-carrier
horses using a standard topical antimicrobial protocol during a
recent CEM outbreak [1] we investigated the addition of a pro-
prietary intramammary antimicrobial formulation for treating
two subsequently-identiﬁed carriers; a mare and gelding. This
combination aimed to reduce the interval to treatment endpointsupported by its reported residual effect and design facilitating
application in the bacterium’s predilection sites. The gelding was
sedated to allow extrusion of the penis before cleaning with a
surfactant (Ducosol®) and scrubbing with 4% chlorhexidine
gluconate (Dismed Bioscrub®). The urethral fossa was thor-
oughly cleaned using chlorhexidine-soaked cotton-tipped
bacteriology swabs. A dry cow intramammary ointment (Cura-
clox®) containing cloxacillin benzathine (600mg) and ampicillin
(300mg) was instilled into the urethral fossa and sinus before
covering the penis with 0.2% nitrofurazone (Furex®) ointment. In
the mare, the clitoral sinus and fossa were similarly cleaned with
Dismed Bioscrub® before thorough cleansing with chlorhexi-
dine-soaked cotton-tipped swabs (clitoral fossa) and paediatric
swabs (clitoral sinus). Thereafter Curaclox® was instilled into the
clitoral sinus and Furex® applied to the clitoral fossa. Prior to
once-daily treatment, genital swabs of all predilection sites were
obtained for detecting T. equigenitalis DNA using a modiﬁcation
of a previously-described qPCR assay [2]. Treatment endpoint
was deﬁned as three consecutive days of Ct > 40 on assay and
conﬁrmed by bacteriology after a 21 day-interval. The table
below shows the interval to elimination of T. equigenitalis
determined by qPCR assay of genital swabs obtained from 27
previously-treated horses (standard protocol) and the mare and
gelding treated with the addition of Curaclox® (combination
treatment).
In conclusion these preliminary data showed a marked reduc-
tion in the interval to elimination of T. equigenitalis in two
horses with the combination treatment. The potential beneﬁts
associated with this promising outcome include economical and
animal welfare considerations and support its further
investigation.References
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